Lankeit M - Search Results

1

Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.

Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, Duerschmied D, Bauersachs R, Empen K, Held M, Schwaiblmair M, Fonseca C, Jiménez D, Becattini C, Quitzau K, Konstantinides S. Barco S, et al. Among authors: lankeit m. Thromb Haemost. 2016 Jul 4;116(1):191-7. doi: 10.1160/TH16-01-0004. Epub 2016 Mar 24. Thromb Haemost. 2016. PMID: 27010343 Clinical Trial.

2

Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.

Puls M, Dellas C, Lankeit M, Olschewski M, Binder L, Geibel A, Reiner C, Schäfer K, Hasenfuss G, Konstantinides S. Puls M, et al. Among authors: lankeit m. Eur Heart J. 2007 Jan;28(2):224-9. doi: 10.1093/eurheartj/ehl405. Epub 2006 Nov 24. Eur Heart J. 2007. PMID: 17127709

3

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2.

Dellas C, Schäfer K, Rohm IK, Lankeit M, Leifheit M, Loskutoff DJ, Hasenfuss G, Konstantinides SV. Dellas C, et al. Among authors: lankeit m. Thromb Haemost. 2007 Nov;98(5):1063-71. Thromb Haemost. 2007. PMID: 18000612

4

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

Lankeit M, Kempf T, Dellas C, Cuny M, Tapken H, Peter T, Olschewski M, Konstantinides S, Wollert KC. Lankeit M, et al. Am J Respir Crit Care Med. 2008 May 1;177(9):1018-25. doi: 10.1164/rccm.200712-1786OC. Epub 2008 Feb 8. Am J Respir Crit Care Med. 2008. PMID: 18263797

5

Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity.

Dellas C, Schäfer K, Rohm I, Lankeit M, Ellrott T, Faustin V, Riggert J, Hasenfuss G, Konstantinides S. Dellas C, et al. Among authors: lankeit m. Thromb Haemost. 2008 Dec;100(6):1123-9. Thromb Haemost. 2008. PMID: 19132239

6

Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group.

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Res. 2009 Dec;124(6):647-8. doi: 10.1016/j.thromres.2009.07.002. Epub 2009 Aug 6. Thromb Res. 2009. PMID: 19664803 No abstract available.

7

Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Res. 2010 Dec;126(6):e407-8. doi: 10.1016/j.thromres.2009.10.010. Epub 2009 Nov 6. Thromb Res. 2010. PMID: 19896704 No abstract available.

8

Thrombolysis for pulmonary embolism: Past, present and future.

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Haemost. 2010 May;103(5):877-83. doi: 10.1160/TH10-01-0005. Epub 2010 Mar 9. Thromb Haemost. 2010. PMID: 20216979 Review.

9

Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.

Dellas C, Puls M, Lankeit M, Schäfer K, Cuny M, Berner M, Hasenfuss G, Konstantinides S. Dellas C, et al. Among authors: lankeit m. J Am Coll Cardiol. 2010 May 11;55(19):2150-7. doi: 10.1016/j.jacc.2009.10.078. J Am Coll Cardiol. 2010. PMID: 20447541 Free article. Clinical Trial.

10

Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism.

Lankeit M, Friesen D, Aschoff J, Dellas C, Hasenfuss G, Katus H, Konstantinides S, Giannitsis E. Lankeit M, et al. Eur Heart J. 2010 Aug;31(15):1836-44. doi: 10.1093/eurheartj/ehq234. Epub 2010 Jun 28. Eur Heart J. 2010. PMID: 20584774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters